Sagimet Biosciences, Inc. (SGMT)
8.03
-0.57
(-6.63%)
USD |
NASDAQ |
Apr 30, 16:00
8.08
+0.05
(+0.62%)
After-Hours: 20:00
Sagimet Biosciences Total Liabilities (Quarterly) : 5.101M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Madrigal Pharmaceuticals, Inc. | 656.90M |
| Omeros Corp. | 446.86M |
| ACADIA Pharmaceuticals, Inc. | 336.80M |
| Agenus, Inc. | 504.66M |
| Alnylam Pharmaceuticals, Inc. | 4.236B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 116.48M |
| Shareholders Equity (Quarterly) | 111.38M |
| Debt to Equity Ratio | 0.0007 |
| Current Ratio | 22.76 |
| Net Debt Paydown Yield | 0.00% |